QQ客服 官方微博 反馈留言

浏览/检索结果: 共11条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Efficacy and safety of nanoparticle-albumin-bound paclitaxel compared with conventional taxanes in women with breast cancer: a systematic review and meta-analysis 期刊论文 ANNALS OF PALLIATIVE MEDICINE, 2022, 卷号: 11 作者:  Lei, Lei;  Chen, Rucheng;  Fan, Lei;  Zheng, Weijun;  Wang, Xiaojia 收藏  |  浏览/下载：27/0  |  提交时间：2022/12/23 Breast cancer  nanoparticle-albumin-bound paclitaxel (Nab-P)  taxanes  meta-analysis   Label-Free Detection and Translocation Dynamics Study of Single-Molecule Herceptin Using Solid-State Nanopores 期刊论文 ADVANCED MATERIALS TECHNOLOGIES, 2022 作者:  Hu, Rui;  Lu, Wenlong;  Wei, Guanghao;  Nan, Hexin;  Li, Juan 收藏  |  浏览/下载：10/0  |  提交时间：2022/12/23 solid-state nanopore  single-molecule detection  protein dynamics  monoclonal antibody  protein unfolding   An antibody-drug conjugate targeting a GSTA glycosite-signature epitope of MUC1 expressed by non-small cell lung cancer 期刊论文 CANCER MEDICINE, 2020, 页码: 12 作者:  Pan, Deng;  Tang, Yubo;  Tong, Jiao;  Xie, Chengmei;  Chen, Jiaxi 收藏  |  浏览/下载：21/0  |  提交时间：2020/12/24 Trastuzumab treatment after progression in HER2-positive metastatic breast cancer following relapse of trastuzumab-based regimens: a meta-analysis 期刊论文 2019, 卷号: 11, 页码: 4699-4706 作者:  Han, Yiqun;  Wang, Jiayu;  Liu, Weiming;  Yuan, Peng;  Li, Qing 收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03 trastuzumab  retreatment  HER2-positive cancer  metastatic cancer of the breast  progression therapy   Metabolic characterization of pyrotinib in humans by ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry 期刊论文 Journal of chromatography b-analytical technologies in the biomedical and life sciences, 2016, 卷号: 1033, 页码: 117-127 作者:  Zhu, Yunting;  Li, Liang;  Zhang, Ge;  Wan, Hong;  Yang, Changyong 收藏  |  浏览/下载：41/0  |  提交时间：2019/05/09 Pyrotinib  Uplc/q-tof ms  Metabolism  Human  Cyp3a4  Drug-drug interaction   Metabolic characterization of pyrotinib in humans by ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry 期刊论文 JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2016, 卷号: 1033, 页码: 117-127 作者:  Zhu, Yunting;  Li, Liang;  Zhang, Ge;  Wan, Hong;  Yang, Changyong 收藏  |  浏览/下载：18/0  |  提交时间：2019/01/08 Pyrotinib  UPLC/Q-TOF MS  Metabolism  Human  CYP3A4  Drug-drug interaction   A miRNA-based signature predicts development of disease recurrence in HER2 positive breast cancer after adjuvant trastuzumab-based treatment 期刊论文 2016, 卷号: 6, 页码: 33825 作者:  Du, F.;  Yuan, P.;  Zhao, Z. T.;  Yang, Z.;  Wang, T. 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04 A miRNA-based signature predicts development of disease recurrence in HER2 positive early breast cancer after adjuvant trastuzumab-based treatment. 期刊论文 2016, 卷号: 34, 期号: 15 作者:  Du, Feng;  Yuan, Peng;  Wang, Jiayu;  Ma, Fei;  Luo, Yang 收藏  |  浏览/下载：2/0  |  提交时间：2020/01/04 HER2 amplification level is not a prognostic factor for HER2-positive breast cancer with trastuzumab-based adjuvant treatment: a systematic review and meta-analysis 期刊论文 2016, 卷号: 7, 期号: 39, 页码: 63571-63582 作者:  Xu, Qian-Qian;  Pan, Bo;  Wang, Chang-Jun;  Zhou, Yi-Dong;  Mao, Feng 收藏  |  浏览/下载：1/0  |  提交时间：2020/01/04 HER2-positive breast cancer  HER2 amplification  prognosis  trastuzumab-based treatment  adjuvant setting   A miRNA-based signature predicts development of disease recurrence in HER2 positive early breast cancer after adjuvant trastuzumab-based treatment. 会议论文 JOURNAL OF CLINICAL ONCOLOGY, 2016-05-20 作者:  Du, Feng;  Yuan, Peng;  Wang, Jiayu;  Ma, Fei;  Luo, Yang 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/04